title: [Minimally invasive surgery for morbid obesity--evidence or fashion?].
abstract: In the last decades surgical treatment for morbid obesity has emerged from being the interest of only few surgeons to a well recognized surgical specialty. This development was promoted by the dramatic increase of prevalence of obesity and the development of laparoscopic surgical techniques. In 1996 the NIH consensus conference stated that bariatric surgery is the most effective therapy to treat obesity and type 2 diabetes, whereas conservative treatment strategies failed in the long-term. Only few studies have compared the different operative strategies. It has been shown that the bypass procedure is better than gastric banding with respect to weight loss and the decrease of comorbidities, but suffers from more short-term morbidity. In recent years, randomized trials have been published comparing laparoscopic with open procedures. These studies show an advantage for the laparoscopic techniques. This paper gives a critical overview on bariatric surgery and summarizes the current literature in this speciality.
authors.affiliation: Klinik für Viszeral- und Transplantationschirurgie, UniversitätsSpital, Zürich.
authors.forename: M K
authors.initials: MK
authors.lastname: Müller
authors.forename: St
authors.initials: S
authors.lastname: Wildi
authors.forename: M
authors.initials: M
authors.lastname: Weber
mesh_terms: D049088:Bariatrics; D015904:Biliopancreatic Diversion; D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D019317:Evidence-Based Medicine; D015390:Gastric Bypass; D015391:Gastroplasty; D006801:Humans; D010535:Laparoscopy; D019060:Minimally Invasive Surgical Procedures; D009767:Obesity, Morbid / Q000453:epidemiology / Q000601:surgery*; D018579:Patient Selection; D015995:Prevalence; D016032:Randomized Controlled Trials as Topic; D015431:Weight Loss